|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/22 HealthLynked Corp. 10-Q 6/30/22 96:7.4M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.18M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 25K
11: R1 Document And Entity Information HTML 76K
12: R2 Condensed Consolidated Balance Sheets HTML 132K
13: R3 Condensed Consolidated Balance Sheets HTML 54K
(Parentheticals)
14: R4 Condensed Consolidated Statement of Operations HTML 126K
(Unaudited)
15: R5 Condensed Consolidated Statement of Changes in HTML 112K
Shareholders' Equity (Deficit) (Unaudited)
16: R6 Condensed Consolidated Statement of Cash Flows HTML 120K
(Unaudited)
17: R7 Business and Business Presentation HTML 33K
18: R8 Significant Accounting Policies HTML 80K
19: R9 Liquidity and Going Concern Analysis HTML 34K
20: R10 Acquisition HTML 35K
21: R11 Prepaid Expenses and Other HTML 32K
22: R12 Property, Plant, and Equipment HTML 33K
23: R13 Intangible Assets and Goodwill HTML 38K
24: R14 Leases HTML 36K
25: R15 Accounts Payable and Accrued Expenses HTML 32K
26: R16 Contract Liabilities HTML 31K
27: R17 Amounts Due to Related Party and Related Party HTML 29K
Transactions
28: R18 Government and Other Notes Payable HTML 30K
29: R19 Convertible Notes Payable HTML 31K
30: R20 Shareholders' Equity HTML 98K
31: R21 Contingent Acquisition Consideration HTML 50K
32: R22 Commitments and Contingencies HTML 39K
33: R23 Segment Reporting HTML 121K
34: R24 Fair Value of Financial Instruments HTML 46K
35: R25 Subsequent Events HTML 32K
36: R26 Accounting Policies, by Policy (Policies) HTML 136K
37: R27 Acquisition (Tables) HTML 38K
38: R28 Prepaid Expenses and Other (Tables) HTML 31K
39: R29 Property, Plant, and Equipment (Tables) HTML 32K
40: R30 Intangible Assets and Goodwill (Tables) HTML 41K
41: R31 Leases (Tables) HTML 36K
42: R32 Accounts Payable and Accrued Expenses (Tables) HTML 31K
43: R33 Contract Liabilities (Tables) HTML 30K
44: R34 Shareholders' Equity (Tables) HTML 101K
45: R35 Contingent Acquisition Consideration (Tables) HTML 43K
46: R36 Commitments and Contingencies (Tables) HTML 30K
47: R37 Segment Reporting (Tables) HTML 114K
48: R38 Fair Value of Financial Instruments (Tables) HTML 47K
49: R39 Business and Business Presentation (Details) HTML 31K
50: R40 Significant Accounting Policies (Details) HTML 67K
51: R41 Liquidity and Going Concern Analysis (Details) HTML 51K
52: R42 Acquisition (Details) HTML 32K
53: R43 Acquisition (Details) - Schedule of summarizes the HTML 34K
fair value
54: R44 Acquisition (Details) - Schedule of assets HTML 44K
acquired and liabilities
55: R45 Acquisition (Details) - Schedule of income HTML 30K
statement
56: R46 Prepaid Expenses and Other (Details) HTML 30K
57: R47 Prepaid Expenses and Other (Details) - Schedule of HTML 42K
prepaid and other expenses
58: R48 Property, Plant, and Equipment (Details) HTML 29K
59: R49 Property, Plant, and Equipment (Details) - HTML 37K
Schedule of property, plant and equipment
60: R50 Intangible Assets and Goodwill (Details) HTML 30K
61: R51 Intangible Assets and Goodwill (Details) - HTML 41K
Schedule of intangible assets
62: R52 Intangible Assets and Goodwill (Details) - HTML 35K
Schedule of goodwill
63: R53 Leases (Details) HTML 32K
64: R54 Leases (Details) - Schedule of lease-related HTML 34K
assets and liabilities
65: R55 Leases (Details) - Schedule of maturities of HTML 45K
operating lease liabilities
66: R56 Accounts Payable and Accrued Expenses (Details) - HTML 38K
Schedule of accounts payable and accrued expenses
67: R57 Contract Liabilities (Details) - Schedule of HTML 34K
amounts related to contract liabilities
68: R58 Amounts Due to Related Party and Related Party HTML 33K
Transactions (Details)
69: R59 Government and Other Notes Payable (Details) HTML 70K
70: R60 Convertible Notes Payable (Details) HTML 40K
71: R61 Shareholders' Equity (Details) HTML 145K
72: R62 Shareholders' Equity (Details) - Schedule of HTML 29K
common stock issuable
73: R63 Shareholders' Equity (Details) - Schedule of stock HTML 52K
warrants
74: R64 Shareholders' Equity (Details) - Schedule of stock HTML 71K
warrants outstanding
75: R65 Shareholders' Equity (Details) - Schedule of fair HTML 44K
value of the warrants
76: R66 Shareholders' Equity (Details) - Schedule of HTML 36K
financial statements with respect to the EIPs
77: R67 Shareholders' Equity (Details) - Schedule of stock HTML 48K
option activity
78: R68 Shareholders' Equity (Details) - Schedule of fair HTML 41K
value of options granted
79: R69 Shareholders' Equity (Details) - Schedule of HTML 41K
non-vested options issued
80: R70 Shareholders' Equity (Details) - Schedule of stock HTML 44K
grant activity
81: R71 Contingent Acquisition Consideration (Details) HTML 71K
82: R72 Contingent Acquisition Consideration (Details) - HTML 39K
Schedule of fair value of contingent acquisition
83: R73 Contingent Acquisition Consideration (Details) - HTML 36K
Schedule of gains (losses) on the change in the
fair value of contingent acquisition
84: R74 Contingent Acquisition Consideration (Details) - HTML 33K
Schedule of maturities of contingent acquisition
consideration
85: R75 Commitments and Contingencies (Details) HTML 36K
86: R76 Commitments and Contingencies (Details) - Schedule HTML 44K
of maturities of operating lease liabilities
87: R77 Segment Reporting (Details) HTML 32K
88: R78 Segment Reporting (Details) - Schedule of segment HTML 143K
information
89: R79 Fair Value of Financial Instruments (Details) - HTML 46K
Schedule of fair value measurements
90: R80 Fair Value of Financial Instruments (Details) - HTML 33K
Schedule of level 3 financial instruments measured
at fair value on recurring basis
91: R81 Subsequent Events (Details) HTML 56K
94: XML IDEA XML File -- Filing Summary XML 182K
92: XML XBRL Instance -- f10q0622_healthlynked_htm XML 1.77M
93: EXCEL IDEA Workbook of Financial Reports XLSX 200K
7: EX-101.CAL XBRL Calculations -- hlyk-20220630_cal XML 122K
8: EX-101.DEF XBRL Definitions -- hlyk-20220630_def XML 975K
9: EX-101.LAB XBRL Labels -- hlyk-20220630_lab XML 1.92M
10: EX-101.PRE XBRL Presentations -- hlyk-20220630_pre XML 953K
6: EX-101.SCH XBRL Schema -- hlyk-20220630 XSD 329K
95: JSON XBRL Instance as JSON Data -- MetaLinks 443± 641K
96: ZIP XBRL Zipped Folder -- 0001213900-22-048070-xbrl Zip 308K
Exhibit 32.2
CERTIFICATIONS
Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of 18 U.S.C. Section 1350), I, George O’Leary, Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “Company”), hereby certify, to my knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 15, 2022 | By: | /s/ George O’Leary |
| Name: | George O’Leary | |
| Title: | Chief Financial Officer (Principal Financial Officer) |
The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/15/22 | None on these Dates | ||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/22/22 HealthLynked Corp. 8-K:2,9 7/19/22 11:266K EdgarAgents LLC/FA 7/08/22 HealthLynked Corp. 8-K:1,9 7/05/22 12:493K EdgarAgents LLC/FA |